Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Ovarian cancer and hormone replacement therapy in the Million Women study

dc.contributor.authorBeral, Valerie
dc.contributor.authorBull, Diana
dc.contributor.authorGreen, Jane
dc.contributor.authorReeves, Gillian K
dc.contributor.authorAustoker, Joan
dc.contributor.authorBanks, Emily
dc.contributor.authorChurch, Judith
dc.contributor.authorEnglish, Ruth
dc.contributor.authorPatnick, Julietta
dc.contributor.authorVessey, Martin
dc.contributor.authorWallis, Matthew G
dc.date.accessioned2015-12-10T22:18:37Z
dc.date.issued2007
dc.date.updated2015-12-09T08:36:32Z
dc.description.abstractBackground: Ovarian cancer is the fourth most common cancer in women in the UK, with about 6700 developing the malignancy and 4600 dying from it every year. However, there is limited information about the risk of ovarian cancer associated with the use of
dc.identifier.issn0140-6736
dc.identifier.urihttp://hdl.handle.net/1885/51486
dc.publisherLancet Publishing Group
dc.sourceLancet, The (UK edition)
dc.subjectKeywords: estrogen; gestagen; oral contraceptive agent; adult; alcohol consumption; article; body mass; cancer mortality; clear cell carcinoma; comparative study; controlled study; disease association; female; follow up; histology; hormone substitution; human; hyst
dc.titleOvarian cancer and hormone replacement therapy in the Million Women study
dc.typeJournal article
local.bibliographicCitation.issue9574
local.bibliographicCitation.lastpage10
local.bibliographicCitation.startpage1703
local.contributor.affiliationBeral, Valerie, University of Oxford
local.contributor.affiliationBull, Diana, University of Oxford
local.contributor.affiliationGreen, Jane, University of Oxford
local.contributor.affiliationReeves, Gillian K, University of Oxford
local.contributor.affiliationAustoker, Joan, University of Oxford
local.contributor.affiliationBanks, Emily, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationChurch, Judith, University of Oxford
local.contributor.affiliationEnglish, Ruth, Radcliffe Infirmary
local.contributor.affiliationPatnick, Julietta, National Health Service Cancer Screening Programmes
local.contributor.affiliationVessey, Martin, Oxford University
local.contributor.affiliationWallis, Matthew G, Coventry and Warwick Hospital
local.contributor.authoruidBanks, Emily, u4106314
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor111706 - Epidemiology
local.identifier.ariespublicationu4105084xPUB225
local.identifier.citationvolume369
local.identifier.doi10.1016/S0140-6736(07)60534-0
local.identifier.scopusID2-s2.0-34248574353
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Beral_Ovarian_cancer_and_hormone_2007.pdf
Size:
6.28 MB
Format:
Adobe Portable Document Format